Tenderwize
Zurück zur Suche

Adquisición vacuna frente al virus respiratorio sincitial (VRS)

Secretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha·Toledo, Spain·EUR 7.9M·Expired · Jul 10, 2026·Open·Supplies
High valueStructured notice only
Originaltitel der Bekanntmachung

Spain – Vaccines – Adquisición vacuna frente al virus respiratorio sincitial (VRS)

70/100

Opportunity Score

Needs reviewMedium complexity
SuppliesExpired
Warum diese Bewertung?

Chance

70 / 100

Komplexität

60 / 100

Risikofaktoren

Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect contract terms or condition...

No procurement documents were analyzed; essential details (e.g., technical specs, contract terms) are unknown.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber
Secretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha
Land
Spanien
CPV
33651600 - Vaccines
Frist
Jul 10, 2026
Geschätzter Wert
EUR 7.9M

Überblick

Moderate opportunity

Wichtige Fakten

  • EUR 7.9M estimated value
  • Supplies contract
  • 1 lot
  • Duration 13 MONTH
  • Supply of VRS vaccine for adult and high-risk populations
  • Duration of 13 months
Vollständige Zusammenfassung anzeigen

Open tender for the supply of a vaccine against Respiratory Syncytial Virus (VRS) for adult and high-risk populations in Castilla-La Mancha, Spain. Single lot, estimated value €7,920,000, 13-month contract. EU-funded according to structured data, but XML notice indicates no EU funds. Award criteria 60% quality, 40% price. Selection criteria include annual turnover and references. Deadline 10 July 2026.

Risiken

Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect contract terms or condition...

No procurement documents were analyzed; essential details (e.g., technical specs, contract terms) are unknown.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

  • Annual turnover and references required for eligibility

Administrative

  • Open procedure, electronic submission required
  • Language: Spanish

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Quality: Co-administration with flu and COVID-19 vaccines (8 points) — 8%Quality: Maximum demonstrated immunity duration (12 points) — 12%Quality: Efficacy evidence in vulnerable subgroups (12 points) — 12%Quality: Level of clinical efficacy evidence (12 points) — 12%Price: Economic offer (40 points) — 40%Quality: Validity period (10 points) — 10%Quality: Pharmaceutical presentation (2 points) — 2%Quality: Replacement for cold chain breakage (4 points) — 4%

Auftraggeber

Lose (1)

LOT-0000

Adquisición vacuna frente al virus respiratorio sincitial (VRS)

Supply of VRS vaccine for adult and high-risk populations.

SuppliesEU fundedElectronic submission

EUR 7.9M

Geschätzter Wert

Ort

ES421, Spain

Dauer

13 MONTH

Kategorie

Vaccines

Zuschlagskriterien

Best price-quality ratio

Frist

Expired Jul 10, 2026

Vergabedetails

Veröffentlichungsdatum
10 Jun 2026
Sprachen
Spanish

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
400931-2026

Dokumente (1)

Ähnliche Ausschreibungen